中心静脉压和肺毛细血管楔压有显著下降。

Central venous pressure and pulmonary capillary wedge pressure also decreased remarkably.

youdao

通过肺动脉导管记录心输出量(CO)、肺毛细血管楔压(PCWP)和中心静脉压(cvp)。

Cardiac output (CO), PCWP and CVP were measured with pulmonary artery catheter.

youdao

静脉注射重组人脑利钠肽能迅速降低急性心力衰竭患者的肺毛细血管楔压，缓解呼吸困难症状，改善预后。

Intravenous recombinant human B-type natriuretic peptide can quickly degrade pulmonary capillary wedge pressure, relieve dyspnea, and improve a patient's prognosis.

youdao

静脉注射重组人脑利钠肽能迅速降低急性心力衰竭患者的肺毛细血管楔压，缓解呼吸困难症状，改善预后。

Intravenous recombinant human B-type natriuretic peptide can quickly degrade pulmonary capillary wedge pressure, relieve dyspnea, and improve a patient's prognosis.

youdao